DANNIE LOY: Open Payments
NPI 1720685308 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$654 in 34 payments from 10 companies in 2025. Trend: 2023 $53 · 2024 $81 · 2025 $654
Food & beverage: $654
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 13 | $215 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $122 |
| Novo Nordisk Inc | 4 | $84 |
| ABBVIE INC. | 2 | $54 |
| Xeris Pharmaceuticals, Inc. | 2 | $40 |
| Intercept Pharmaceuticals, Inc. | 2 | $38 |
| Ipsen Biopharmaceuticals, Inc | 2 | $32 |
| Merck Sharp & Dohme LLC | 1 | $28 |
| SANOFI-AVENTIS U.S. LLC | 1 | $24 |
| ViiV Healthcare Company | 1 | $15 |
Products named: REZDIFFRA, XIFAXAN, Wegovy, MAVYRET, GVOKE HYPOPEN, OCALIVA, PIFELTRO, TZIELD.
Industry payments across AR — which companies pay providers there.
